News
🇪🇺 EMALatest pharmaceutical news, drug approvals, and EMA regulatory updates
Showing 1–12 of 363 articles
Quick answer
NovaPharmaNews Europe & United Kingdom news feed tracks 363 published stories — EMA regulatory actions, clinical trial readouts, M&A, and commercial milestones for pharma BD, investors, and market access teams. Browse by topic, explore linked company and drug profiles, or switch to analysis for deeper commentary.
EC Approves Itvisma Gene Therapy for SMA 2+
CHMP Backs Lyrokaul Monthly PCSK9 Shot
EC Approves TEPKINLY Plus R2 for Follicular Lymphoma
CHMP Backs Lynavoy for PBC Itch
CHMP Backs Nezglyal for Cerebral ALD in Boys
CHMP July 2026: 12 New Medicines Recommended
EC Approves Wegovy Pill, First Oral GLP-1 in EU
CHMP Backs Obicetrapib Ubeslo and Evlarco
EMA Backs Icotyde, First Oral IL-23R Psoriasis Drug
EMA Recommends Susvimo Implant for Wet AMD
Eli Lilly to Acquire AtaiBeckley for $2.8B
Chinese drugmakers struggle to recruit for EU
Frequently asked questions
What does the regional news feed cover?
Breaking pharmaceutical news for the selected edition — regulatory actions, clinical readouts, corporate announcements, partnerships, and market-moving signals. Each story links to company profiles, drug INN pages, trials, and events where entities are tagged.
How is news different from analysis on NovaPharmaNews?
News covers timely regulatory and commercial developments. Analysis & Commentary provides in-depth opinion, market context, and expert interpretation. Use the content-type chips above to switch between latest news and analysis hubs.
How often is this feed updated?
New articles publish continuously as FDA, EMA, PMDA, NMPA, and other agency signals break. Subscribe to the weekly digest in the sidebar for a curated Monday roundup.